Approval · Notice of Compliance 21844 · 2019
FLURBIPROFEN: Notice of Compliance 21844
Issued February 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21844
- Date
- February 12, 2019
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership Change in product name Revisions to the Product Monograph Revisisions to the inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLURBIPROFEN | 01912046 | Marketed |
| FLURBIPROFEN | 01912038 | Marketed |
Medicinal ingredients
- FLURBIPROFEN 50 MG per TAB
- FLURBIPROFEN 100 MG per TAB